Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 25:2018:4920841.
doi: 10.1155/2018/4920841. eCollection 2018.

Clinical Characteristics of Aldosterone- and Cortisol-Coproducing Adrenal Adenoma in Primary Aldosteronism

Affiliations

Clinical Characteristics of Aldosterone- and Cortisol-Coproducing Adrenal Adenoma in Primary Aldosteronism

Lu Tang et al. Int J Endocrinol. .

Abstract

Aldosterone- and cortisol-coproducing adrenal adenoma (A/CPA) cases have been observed in patients with primary aldosteronism (PA). This study investigated the incidence, clinical characteristics, and molecular biological features of patients with A/CPAs. We retrospectively identified 22 A/CPA patients from 555 PA patients who visited the Chinese People's Liberation Army General Hospital between 2004 and 2015. Analysis of clinical parameters revealed that patients with A/CPAs had larger tumors than those with pure APAs (P < 0.05). Moreover, they had higher proportions of cardiovascular complications, glucose intolerance/diabetes, and osteopenia/osteoporosis compared to the pure APA patients (P < 0.001). In the molecular biological findings, quantitative real-time PCR analysis revealed similar CYP11B1 and CYP17A1 mRNA expressions in resected A/CPA specimens and in pure APA specimens. Western blot and immunochemical analyses showed CYP11B1, CYP11B2, and CYP17A1 expressions in both A/CPAs and pure APAs. Seventeen cases with KCNJ5 mutations were detected among the 22 A/CPA DNA samples, but no PRKACA or other causative mutations were observed. Each patient improved following adrenalectomy. In conclusion, A/CPAs were not rare among PA patients. These patients associated with high incidences of cardiovascular events and metabolic disorders. Screening for excess cortisol secretion is necessary for PA patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CYP11B1, CYP11B2, and CYP17A1 mRNA and protein expression levels in A/CPA tissue, pure APA tissue, and normal adrenal glands (NAGs). (a) Western blot showing CYP11B1, CYP11B2, and CYP17A1 protein bands in the A/CPA, pure APA, and NAG tissues. (b) The intensity of the CYP11B1, CYP11B2, and CYP17A1 protein bands compared with β-actin. (c) CYP11B1, CYP11B2, and CYP17A1 mRNA expressions in A/CPA, pure APA, and NAG tissues. P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001.
Figure 2
Figure 2
Immunohistochemistry results for CYP11B1, CYP11B2, CYP17A1, and hematoxylin-eosin stain (HES) in A/CPA and pure APA tissue.

References

    1. Conn J. W. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. The Journal of Laboratory and Clinical Medicine. 1955;45(1):3–17. - PubMed
    1. Funder J. W., Carey R. M., Fardella C., et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2008;93(9):3266–3281. doi: 10.1210/jc.2008-0104. - DOI - PubMed
    1. Stowasser M., Gordon R. D. Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney. Physiological Reviews. 2016;96(4):1327–1384. doi: 10.1152/physrev.00026.2015. - DOI - PubMed
    1. Stowasser M., Sharman J., Leano R., et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. The Journal of Clinical Endocrinology & Metabolism. 2005;90(9):5070–5076. doi: 10.1210/jc.2005-0681. - DOI - PubMed
    1. Mosso L., Carvajal C., Gonzalez A., et al. Primary aldosteronism and hypertensive disease. Hypertension. 2003;42(2):161–165. doi: 10.1161/01.HYP.0000079505.25750.11. - DOI - PubMed

LinkOut - more resources